David Coffey, MD (IMAGE)
Caption
“Our study underscores how critically important the immune system is to patients’ ability to respond favorably – and achieve remission – through current therapies for multiple myeloma,” said David Coffey, MD, Sylvester hematologic oncologist and researcher.
Credit
Photo by Sylvester
Usage Restrictions
None
License
Original content